• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病加重胆管炎并促进小鼠胆管细胞癌的发生。

NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.

机构信息

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Division of Gastroenterology, Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.

出版信息

Cancer Sci. 2021 Apr;112(4):1471-1480. doi: 10.1111/cas.14828. Epub 2021 Feb 14.

DOI:10.1111/cas.14828
PMID:33506599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8019203/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition, affecting up to 25% of the population worldwide. NAFLD has been linked to several conditions, including hepatic inflammation, fibrosis, and hepatocellular carcinoma (HCC), however the role of NAFLD in cholangitis and the development of cholangiocellular carcinoma (CCC) remains poorly understood. This study investigated whether a high-fat diet (HFD) promotes cholangitis and the development of CCC in mice. We used liver-specific E-cadherin gene (CDH1) knockout mice, CDH1 , which develop spontaneous inflammation in the portal areas along with periductal onion skin-like fibrosis, similar to that of primary sclerosing cholangitis (PSC). An HFD or normal diet (ND) was fed to CDH1 mice for 7 mo. In addition, CDH1 mice were crossed with LSL-Kras mice, fed an HFD, and assessed in terms of liver tumor development. The extent of cholangitis and number of bile ductules significantly increased in mice fed an HFD compared with ND-administered CDH1 mice. The numbers of Sox9 and CD44-positive stem cell-like cells were significantly increased in HFD mice. LSL-Kras /CDH1 HFD mice exhibited increased aggressiveness along with the development of numerous HCC and CCC, whereas LSL-Kras /CDH1 ND mice showed several macroscopic tumors with both HCC and CCC components. In conclusion, NAFLD exacerbates cholangitis and promotes the development of both HCC and CCC in mice.

摘要

非酒精性脂肪性肝病(NAFLD)是一种越来越常见的疾病,全球范围内多达 25%的人群受到影响。NAFLD 与多种疾病有关,包括肝炎症、纤维化和肝细胞癌(HCC),但 NAFLD 在胆管炎和胆管细胞癌(CCC)发展中的作用仍知之甚少。本研究旨在探讨高脂肪饮食(HFD)是否会促进小鼠的胆管炎和 CCC 发展。我们使用了肝特异性 E-钙黏蛋白基因(CDH1)敲除小鼠 CDH1 ,这些小鼠在门脉区域自发炎症,并伴有伴胆管周围洋葱皮样纤维化,类似于原发性硬化性胆管炎(PSC)。将 HFD 或正常饮食(ND)喂养 CDH1 小鼠 7 个月。此外,将 CDH1 小鼠与 LSL-Kras 小鼠杂交,给予 HFD,并评估其肝肿瘤的发展情况。与给予 ND 的 CDH1 小鼠相比,HFD 喂养的小鼠胆管炎的严重程度和胆管小管的数量显著增加。HFD 小鼠 Sox9 和 CD44 阳性干细胞样细胞的数量明显增加。LSL-Kras/CDH1 HFD 小鼠表现出侵袭性增加,同时伴有大量 HCC 和 CCC 的发展,而 LSL-Kras/CDH1 ND 小鼠则表现出多个具有 HCC 和 CCC 成分的大体肿瘤。总之,NAFLD 可加重胆管炎,并促进小鼠 HCC 和 CCC 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/bf8507e314dd/CAS-112-1471-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/36d8f9b0e7d2/CAS-112-1471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/1f987b0f5cd1/CAS-112-1471-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/69dd84b6f757/CAS-112-1471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/9cd1f9b0164e/CAS-112-1471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/95081adffeed/CAS-112-1471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/025fd6627306/CAS-112-1471-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/bf8507e314dd/CAS-112-1471-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/36d8f9b0e7d2/CAS-112-1471-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/1f987b0f5cd1/CAS-112-1471-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/69dd84b6f757/CAS-112-1471-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/9cd1f9b0164e/CAS-112-1471-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/95081adffeed/CAS-112-1471-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/025fd6627306/CAS-112-1471-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a0/8019203/bf8507e314dd/CAS-112-1471-g008.jpg

相似文献

1
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.非酒精性脂肪性肝病加重胆管炎并促进小鼠胆管细胞癌的发生。
Cancer Sci. 2021 Apr;112(4):1471-1480. doi: 10.1111/cas.14828. Epub 2021 Feb 14.
2
Roles of E-cadherin in HepatocarcinogenesisE-钙黏蛋白在肝癌发生中的作用
3
Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.两种非酒精性脂肪性肝病膳食小鼠模型引起的代谢和肝脏病理生物学差异。
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E863-E876. doi: 10.1152/ajpendo.00321.2020. Epub 2020 Sep 14.
4
Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.在喂食胆碱缺乏、L-氨基酸限定的高脂肪饮食的小鼠模型中的肝细胞癌。
Int J Exp Pathol. 2017 Aug;98(4):221-233. doi: 10.1111/iep.12240. Epub 2017 Sep 12.
5
Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.瑞舒伐他汀作为一种潜在的预防性药物,用于预防小鼠非酒精性脂肪性肝病相关肝细胞癌的发生。
Int J Mol Med. 2016 Nov;38(5):1499-1506. doi: 10.3892/ijmm.2016.2766. Epub 2016 Oct 3.
6
AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease.喂食高反式脂肪、高胆固醇饮食的AIM缺陷小鼠:一种非酒精性脂肪性肝病的新动物模型。
Exp Anim. 2019 May 8;68(2):147-158. doi: 10.1538/expanim.18-0108. Epub 2018 Nov 28.
7
A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet.链脲佐菌素和高脂饮食诱导的肝癌小鼠模型。
Methods Mol Biol. 2024;2769:67-75. doi: 10.1007/978-1-0716-3694-7_5.
8
Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.非酒精性脂肪性肝病表现出纤维化前和癌前的分子特征。
Dig Dis Sci. 2019 May;64(5):1257-1269. doi: 10.1007/s10620-018-5398-4. Epub 2018 Dec 5.
9
The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.αvβ6 整联蛋白是胆管癌的高度特异性免疫组化标志物。
J Hepatol. 2010 Mar;52(3):362-9. doi: 10.1016/j.jhep.2009.12.006. Epub 2010 Jan 13.
10
Activation of CDK4 Triggers Development of Non-alcoholic Fatty Liver Disease.CDK4的激活引发非酒精性脂肪性肝病的发展。
Cell Rep. 2016 Jul 19;16(3):744-56. doi: 10.1016/j.celrep.2016.06.019. Epub 2016 Jun 30.

引用本文的文献

1
SOX9: a key transcriptional regulator in organ fibrosis.SOX9:器官纤维化中的关键转录调节因子。
Front Pharmacol. 2025 Feb 5;16:1507282. doi: 10.3389/fphar.2025.1507282. eCollection 2025.
2
Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights.心血管代谢综合征与胆道癌的相互作用:一项具有性别特异性见解的综合分析。
Cancers (Basel). 2024 Oct 9;16(19):3432. doi: 10.3390/cancers16193432.
3
Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics.

本文引用的文献

1
Liver Cancer: Current and Future Trends Using Biomaterials.肝癌:生物材料的现状与未来趋势
Cancers (Basel). 2019 Dec 16;11(12):2026. doi: 10.3390/cancers11122026.
2
Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.人类肝细胞癌中E-钙黏蛋白信号传导的遗传与表观遗传调控
Cancer Manag Res. 2019 Oct 16;11:8947-8963. doi: 10.2147/CMAR.S225606. eCollection 2019.
3
Methylation of tumour suppressor genes and in HCV-related liver cirrhosis and hepatocellular carcinoma.肿瘤抑制基因的甲基化与丙型肝炎病毒相关肝硬化及肝细胞癌
与脂肪性肝病相关的基因变异:诊断与治疗的机遇
Biomedicines. 2023 Oct 17;11(10):2809. doi: 10.3390/biomedicines11102809.
4
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.代谢功能障碍相关脂肪性肝病相关肝肿瘤的病理学与发病机制
Biomedicines. 2023 Oct 12;11(10):2761. doi: 10.3390/biomedicines11102761.
5
Association of nonalcoholic fatty liver disease with acute cholangitis: a nationwide propensity-matched analysis from the United States.非酒精性脂肪性肝病与急性胆管炎的关联:一项来自美国的全国性倾向匹配分析。
Proc (Bayl Univ Med Cent). 2023 Jul 17;36(5):600-607. doi: 10.1080/08998280.2023.2231721. eCollection 2023.
6
Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study.胆管癌危险因素的研究:一项孟德尔随机化研究。
Front Pharmacol. 2022 Aug 26;13:900424. doi: 10.3389/fphar.2022.900424. eCollection 2022.
7
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.为胆管癌研究选择合适的实验动物模型。
J Clin Transl Hepatol. 2022 Aug 28;10(4):700-710. doi: 10.14218/JCTH.2021.00374. Epub 2022 Feb 11.
8
Current Advances in Basic and Translational Research of Cholangiocarcinoma.胆管癌基础与转化研究的当前进展
Cancers (Basel). 2021 Jul 1;13(13):3307. doi: 10.3390/cancers13133307.
Br J Biomed Sci. 2020 Jan;77(1):35-40. doi: 10.1080/09674845.2019.1694123. Epub 2019 Dec 2.
4
Cancer mortality in Europe in 2015 and an overview of trends since 1990.2015 年欧洲癌症死亡率及自 1990 年以来的趋势概述。
Ann Oncol. 2019 Aug 1;30(8):1356-1369. doi: 10.1093/annonc/mdz179.
5
Molecular Pathogenesis of Cholangiocarcinoma.胆管癌的分子发病机制。
BMC Cancer. 2019 Feb 28;19(1):185. doi: 10.1186/s12885-019-5391-0.
6
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.肝脏疾病中的胆小管反应:病理机制与转化意义。
Hepatology. 2019 Jan;69(1):420-430. doi: 10.1002/hep.30150. Epub 2018 Dec 27.
7
Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.阻断白介素-15 可消除饮食诱导肥胖小鼠的实验性免疫介导性胆管炎。
Sci Rep. 2018 Feb 15;8(1):3127. doi: 10.1038/s41598-018-21112-7.
8
Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的全球流行病学:我们未来的需求。
Liver Int. 2018 Feb;38 Suppl 1:47-51. doi: 10.1111/liv.13643.
9
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.美国肝内和肝外胆管癌的危险因素:一项基于监测、流行病学和最终结果(SEER)-医疗保险计划的人群研究
PLoS One. 2017 Oct 19;12(10):e0186643. doi: 10.1371/journal.pone.0186643. eCollection 2017.
10
Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.酒精性、非酒精性和毒物相关性脂肪性肝炎:机制上的异同
Cell Mol Gastroenterol Hepatol. 2015 Jun 3;1(4):356-367. doi: 10.1016/j.jcmgh.2015.05.006. eCollection 2015 Jul.